Genome-scale screen for DNA methylation-based detection markers for ovarian cancer

• Main Authors: Campan M., Moffitt M., Houshdaran S., Shen H., Widschwendter M., Daxenbichler G., Long T., Marth C., Laird-Offringa I.A., Press M.F., Dubeau L., Siegmund K.D., Wu A.H., Groshen S., Chandavarkar U., Roman L.D., Berchuck A., Pearce C.L., Laird P.W.
• Other Authors: MICROBIOLOGY AND IMMUNOLOGY
• Format: Article
• Published: 2019
• Subjects: CA 125 antigen; DNA; tumor marker; article; cancer diagnosis; cancer patient; cancer recurrence; cancer surgery; clear cell carcinoma; controlled study; CpG island; DNA determination; DNA extraction; DNA methylation; endometrioid carcinoma; female; genetic screening; human; leukocyte; mucinous carcinoma; ovary cancer; promoter region; sensitivity analysis; biosynthesis; blood; blood clotting; gene expression regulation; genetic epigenesis; genetics; genotype; human genome; kinetics; longitudinal study; metabolism; ovary tumor; reproducibility; risk; Blood Coagulation; CA-125 Antigen; CpG Islands; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genome, Human; Genotype; Humans; Kinetics; Longitudinal Studies; Odds Ratio; Ovarian Neoplasms; Reproducibility of Results; Tumor Markers, Biological
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/162019
• Institution: National University of Singapore

10.1371/journal.pone.0028141